Comparison of precise drug therapy in obese patients during perioperative period

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17013365

Enrollment

Unknown

Registered

2017-11-13

Start date

2017-12-01

Completion date

Unknown

Last updated

2017-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

A:omeprazole intravenous injection to maintain

B:omeprazole intravenous infusion

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with obese after sleeve gastrectomy or gastric bypass flow surgery (BMI = 26kg / m2); Patients older than 18 years old.;Inclusion criteria: Patients with obese after sleeve gastrectomy or gastric bypass flow surgery (BMI = 26kg / m2); Patients older than 18 years old.

Exclusion criteria

Exclusion criteria: Patients with a history of long-term proton pump inhibitors;Exclusion criteria: Patients with a history of long-term proton pump inhibitors

Design outcomes

Primary

Measure	Time frame
serum drug concentration of omeprazole;;serum drug concentration of omeprazole;	—

Countries

China

Contacts

Public ContactHuang Weifeng;Huang Weifeng ;

Shanghai 6th People's Hospital;Shanghai 6th People's Hospital

364512121@qq.com;364512121@qq.com+86 18930173670;+86 18930173670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026